Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
4 of 6 columns
Comparison
| Attribute | UBIVAC, INC.4.5remove | MalarVx, Inc.4.6remove | Candor Therapeutics Inc.4.4remove | Citrachem Corp.4.4remove |
|---|---|---|---|---|
| Signal scores | ||||
| Radar composite | 4.5 | 4.6 | 4.4 | 4.4 |
| IPO signal score | 9.0 | 9.2 | 8.9 | 8.8 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE+2.5 | STABLE+2.6 | STABLE+2.4 | STABLE+2.4 |
| Company | ||||
| Stage | private | private | private | private |
| Sector | Technology | Technology | Technology | Technology |
| Headquarters | PORTLAND, United States | SEATTLE, United States | Sunnyvale, United States | NORWOOD, United States |
| Founded | not on record | not on record | 2026 | not on record |
| Employees | not on record | not on record | not on record | not on record |
| Capital | ||||
| Latest valuation | not on record | not on record | not on record | not on record |
| Total funding | $80K | $125K | $50K | $50K |
| Latest round | Private Placement $80K | Private Placement $125K | Private Placement $50K | Private Placement $50K |
| Investors on record | 0 | 0 | 0 | 0 |
| Evidence | ||||
| Institutional relationships | 0 | 0 | 0 | 0 |
| Active signals | 1 | 1 | 1 | 1 |
| Confidence | 53% | 53% | 53% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.